Home Applications 217900 Application 217900
Type NDA
Sponsor SUN PHARM INDS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LEQSELVI DEURUXOLITINIB PHOSPHATE TABLET;ORAL EQ 8MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217900-001 LEQSELVI DEURUXOLITINIB PHOSPHATE EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217900-001 10561659 2037-05-04 U-3976 2024-08-23 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 N217900-001 12285432 2042-08-11 U-3976 2025-05-29 N217900-001 12247034 2044-05-10 Drug substance, Drug product 2025-04-08 N217900-001 12364699 2044-10-10 U-3976 2025-08-21
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217900-001 NCE 2029-07-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 79d66fd596c7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217900-001 LEQSELVI EQ 8MG BASE TABLET / ORAL RLD, RS 2024-07-25 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217900-001 12285432 2042-08-11 U-3976 2025-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217900-001 12247034 2044-05-10 Drug substance, Drug product 2025-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217900-001 12364699 2044-10-10 U-3976 2025-08-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 12285432 2042-08-11 U-3976 2025-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 12247034 2044-05-10 Drug substance, Drug product 2025-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 12364699 2044-10-10 U-3976 2025-08-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217900-001 12285432 2042-08-11 U-3976 2025-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217900-001 12247034 2044-05-10 Drug substance, Drug product 2025-04-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217900-001 10561659 2037-05-04 U-3976 2024-08-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217900-001 12076323 2037-05-04 U-3976 2024-10-01 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217900-001 11919907 2041-05-21 U-3976 Drug product 2024-08-23 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217900-001 NCE 2029-07-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217900-001 NCE 2029-07-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217900-001 NCE 2029-07-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217900-001 NCE 2029-07-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217900-001 NCE 2029-07-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217900-001 NCE 2029-07-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217900-001 NCE 2029-07-25 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217900-001 NCE 2029-07-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217900-001 NCE 2029-07-25 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217900-001 NCE 2029-07-25 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join LEQSELVI DEURUXOLITINIB PHOSPHATE Sun Pharmaceutical Industries, Inc. a603f231-d09e-4bad-ad5e-b55f865da095 2026-07-13 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 217900 application number: NDA217900
Documents# Document, Submission type, Date table Document Submission type Date 79464 ORIG 2024-08-23 79317 ORIG 2024-08-06 79240 ORIG 2024-08-06 79242 ORIG 2024-07-29